NEUROTROPE BIOSCIENCE, INC. Business Finance Contracts & Agreements
17 Contracts & Agreements
- Purchase Agreements (4 contracts)
- Registration Rights Agreements (3)
- Stock Agreements (2)
- Warrant Agreements (8)
- First Amendment to the Securities Purchase Agreement dated as of May 11, 2023 by and among Synaptogenix, Inc. and certain investors party thereto (Filed With SEC on May 15, 2023)
- Form of Registration Rights Agreement (Filed With SEC on November 18, 2022)
- Form of Purchase Agreement (Filed With SEC on November 18, 2022)
- Form of Warrant (Filed With SEC on November 18, 2022)
- Registration Rights Agreement, dated June 14, 2021, by and among Synaptogenix, Inc. and the Buyers signatory thereto (Filed With SEC on June 16, 2021)
- Form of Series G Warrant (Filed With SEC on June 16, 2021)
- Form of Pre-Funded Warrant (Filed With SEC on June 16, 2021)
- Form of Broker Warrant (Filed With SEC on June 16, 2021)
- Securities Purchase Agreement, dated June 14, 2021, by and among Synaptogenix, Inc. and the Buyers signatory thereto (Filed With SEC on June 16, 2021)
- Registration Rights Agreement, dated January 21, 2021, by and among Synaptogenix, Inc. and the Buyers signatory thereto (Filed With SEC on January 22, 2021)
- Securities Purchase Agreement, dated January 21, 2021, by and among Synaptogenix, Inc. and the Buyers signatory thereto (Filed With SEC on January 22, 2021)
- Form of Broker Warrant (Filed With SEC on January 22, 2021)
- Form of Pre-Funded Warrant (Filed With SEC on January 22, 2021)
- Form of Series F Warrant (Filed With SEC on January 22, 2021)
- Form of Series E Warrant (Filed With SEC on January 22, 2021)
- Rights Agreement, dated as of January 19, 2021, between Synaptogenix, Inc. and Philadelphia Stock Transfer, Inc., as rights agent (Filed With SEC on January 19, 2021)
- Specimen Common Stock Certificate (Filed With SEC on October 30, 2020)
